COMPASS-Print-AD


A randomized controlled trial of rivaroxaban for the prevention of major cardiovascular events in patients with coronary or peripheral artery disease (COMPASS – Cardiovascular OutcoMes for People using Anticoagulation Strategies)

Click here for more information.


Register Today!

Let others know about this Trial!

Trial Information

Start Date2013
End Date2020
Trial DurationUp to 5 years
Number of Visits15
Lead CRCMichael Ricci-Bonzey
StatusOn-Going

For additional information
on this trial contact:

Phone705-566-0005